TAXUS Libertē Post Approval Study

NCT00997503 · clinicaltrials.gov ↗

COMPLETED

Status

4199

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DEVICE: TAXUS Liberté Paclitaxel-Eluting Coronary Stent
DRUG: prasugrel
DRUG: placebo
DRUG: aspirin

Sponsor

Boston Scientific Corporation

Collaborators

[object Object]
[object Object]